Home » India Details Stability Test Prerequisites for Clinical Trials
India Details Stability Test Prerequisites for Clinical Trials
January 10, 2012
Sponsors must ensure the stability of investigational drug products before beginning clinical trials and bioequivalence studies in India, according to the Central Drugs Standard Control Organization (CDSCO).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor